Search

everythinglearnresearchcommunity

for

Search:↓

Electric pulses can effectively activate platelets and release growth factors, offering a better alternative to traditional methods.

Pulsed electric field treatment may help the immune system fight liver tumors.

Post-finasteride syndrome causes various symptoms in men using finasteride, with no known cure.

EPF can occur without visible pustules.

Men with self-diagnosed PFS-related ED have normal erectile hemodynamics.

Younger people (median age 35) experience more PFS-like symptoms with 1mg finasteride; more research needed.

PFS might be a delusional disorder with potential to become mass psychogenic illness.

Post-finasteride syndrome is rarely linked to sexual and systemic side effects.

Post-finasteride syndrome causes lasting sexual, neurological, and physical side effects in some people after taking finasteride.

Clinicians need to better understand and treat Post-finasteride syndrome.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

Post-finasteride syndrome can cause lasting sexual, physical, and mental health issues with limited treatment options.

Gene expression differences in PFS patients suggest a potential organic cause for symptoms.

The true incidence of post-Finasteride syndrome is unclear, and more research is needed.

Post-finasteride syndrome's existence is uncertain; more research needed.

Some patients fail bladder function tests due to lower flow rates and higher remaining urine volumes, but the exact reasons for failure are unclear.

Post-drug syndromes are often overlooked, and better systems and education are needed to improve drug safety.

PFAS exposure in adolescence may delay puberty in females.

Perifollicular elastolysis is poorly understood, with limited treatment options and inconsistent results.

Most dermatologists think post-finasteride syndrome is rare, possibly psychiatric, and needs more research.

Finasteride can cause serious side effects in some men, needing more research for treatment.

EFFC might be common but underreported.

Post-Exposure Syndromes are persistent conditions caused by past exposures, needing unique interventions.

Current drug safety systems fail to detect long-term side effects, needing improvements to protect health and trust.

Pegvaliase is recommended for treating adults with phenylketonuria.

Finasteride increases P-glycoprotein activity in the liver and kidney.

The cause of post-finasteride syndrome is unclear and needs more research.

Post-exposure syndromes are persistent conditions caused by past exposures, needing unique interventions.

Some men experience persistent sexual, neurological, and psychological symptoms after stopping finasteride, but evidence of permanent damage is inconclusive.

Finasteride's link to health issues like male breast cancer, infertility, and prostate cancer needs more research through placebo-controlled trials to confirm.